Nucana closes IPO at $114m

Nucana closes IPO at $114m

A PIONEERING medical firm which develops techniques to boost the effectiveness of chemotherapy has raised almost £75 million by floating on the stock market.

Edinburgh-based NuCana, which began trading yesterday on the NASDAQ stock market in New York, will use the windfall to fund further clinical trials and expand in the capital.

More here: http://www.heraldscotland.com/news/15565116